[Therapeutic effects of cefoxitin in the treatment of various infections in children (author's transl)].

Author: HamawakiM, KitamuraI, KurashigeT, NishibayashiY, OzakiH, WakiguchiH

Paper Details 
Original Abstract of the Article :
In order to ascertain the therapeutic effects of cefoxitin (CFX), a new semisynthetic cephamycin antibiotic, it was administered to pediatric patients with several infections. There were 8 patients with acute respiratory disease (ARD), 3 with urinary tract infection (UTI), 2 with appendicitis compli...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/7289030

データ提供:米国国立医学図書館(NLM)

Cefoxitin: A Powerful Weapon Against Pediatric Infections

The world of pediatrics is constantly seeking effective and safe treatments for a variety of infections. This research focuses on the efficacy of cefoxitin (CFX), a new semisynthetic cephamycin antibiotic, in treating infections in children. The study investigated the clinical and bacteriological effects of CFX across a range of infections in a diverse group of pediatric patients.

Cefoxitin: A Strong Performer in Pediatric Infections

The study found that CFX showed a high efficacy rate of 95% in treating various infections in children. The drug demonstrated effectiveness against a range of bacterial infections, including acute respiratory disease (ARD), urinary tract infection (UTI), scarlet fever, and others. Interestingly, CFX was found to be superior to other cephalosporins in treating infections caused by E. coli, suggesting its potential as a valuable tool in treating this specific type of bacterial infection.

A Promising New Tool for Pediatric Care

Cefoxitin’s effectiveness and safety in treating various infections in children make it a promising new tool for pediatric care. It’s like finding a new, stronger camel to carry a heavy load – more effective and reliable for the journey ahead.

Dr.Camel's Conclusion

Cefoxitin is a promising new antibiotic for treating infections in children. It’s like finding a new, potent antidote for a venomous snakebite – effective and safe for those in need.

Date :
  1. Date Completed 1981-12-21
  2. Date Revised 2016-11-16
Further Info :

Pubmed ID

7289030

DOI: Digital Object Identifier

7289030

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.